Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Health World Ukraine.
Kyivstar Launches Locally Hosted AI Platform In Its Cloud
KYIV, Ukraine, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Kyivstar Group Ltd (Nasdaq: KYIV; KYIVW) (“Kyivstar”), a national digital communications operator, today announced it has begun integrating artificial intelligence (AI) technologies into its...
My journey as a Ukrainian healthcare professional: a story of resilience and hope
In this blog, Dr Inna Soldatenko shares her experience of navigating the challenges posed by the ongoing war in Ukraine. Today, I want to share my story with you because it reflects the experiences of so many Ukrainian healthcare professionals who...
Owner: Royal College of Physicians (Non-profit)
My journey as a Ukrainian healthcare professional: a story of resilience and hope
In this blog, Dr Inna Soldatenko shares her experience of navigating the challenges posed by the ongoing war in Ukraine. Today, I want to share my story with you because it reflects the experiences of so many Ukrainian healthcare professionals who...
Owner: Royal College of Physicians (Non-profit)
Cosmos Health CEO Issues Letter to Shareholders: Building a Global Healthcare Powerhouse with $300M Digital Financing Facility, U.S. Manufacturing Expansion, and AI Innovation
CHICAGO, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that its Chief Executive Officer, Greg Siokas, has...
Poland Implements Stricter Regulations for Ukrainian Refugees
(MENAFN) Poland’s President, Karol Nawrocki, has enacted a new law that imposes stricter requirements on Ukrainian refugees seeking access to public benefits. Although the legislation permits Ukrainians to remain in Poland until at least March...
Owner: Sawsan Dababneh & Ramzi AbdelJaber
UNGA80 High-Level Side Event: 'No Health Without Mental Health: A shared commitment'
Leaders and experts from around the world gathered at the UN General Assembly high-level side event “No Health Without Mental Health: A shared commitment." NEW YORK, NY, UNITED STATES, September 26, 2025 /EINPresswire.com/ -- Leaders and experts...
Minister Fajon calls on UN Security Council to take decisive action on wars in Ukraine and Gaza
SLOVENIA, September 23 - The Minister also participated in a side event on the return of Ukrainian children, organised by Ukrainian President Volodymyr Zelenskyy and Canadian Prime Minister Mark Carney. She emphasised that children are the...
Owner: Slovenian Government
Zealand Pharma appoints Rachel James-Owens as Vice President, Corporate Communications & Media Relations
Press release – No. 14 / 2025 Zealand Pharma appoints Rachel James-Owens as Vice President, Corporate Communications & Media Relations Copenhagen, Denmark, September 24, 2025 - Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology...
XOMA Royalty Extends Tender Offer to Acquire LAVA Therapeutics N.V.
EMERYVILLE, Calif. and UTRECHT, The Netherlands and PHILADELPHIA, Oct. 02, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (“XOMA Royalty”) (NASDAQ: XOMA) and LAVA Therapeutics N.V. (“LAVA”) (Nasdaq: LVTX) today announced the extension of the...
Ukraine’s Reconstruction Offers Opportunities for Turkish Firms
(MENAFN) Ukraine is set to provide substantial prospects during its reconstruction phase, with the total project volume reaching over $50 billion for Turkish companies to participate in, according to Eyup Vural Aydin, chairman of the...
Owner: Sawsan Dababneh & Ramzi AbdelJaber
European Medicines Agency Recommends Marketing Approval of Gobivaz®, Alvotech’s Proposed Biosimilar to Simponi® (golimumab) with Advanz Pharma as Commercialization Partner
REYKJAVIK, ICELAND and LONDON, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma Holdco Limited...
European Medicines Agency Recommends Marketing Authorization of AVT03, Alvotech’s Proposed Biosimilar to Prolia® and Xgeva®
REYKJAVIK, Iceland, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the European Medicines...
Ukraine reports casualties in Recent Russian strikes
(MENAFN) Ukraine announced on Tuesday that two individuals lost their lives while 14 others sustained injuries following overnight Russian assaults on Zaporizhzhia and the nearby Polohivskyi district. “Two people were killed and 14 were injured as...
Owner: Sawsan Dababneh & Ramzi AbdelJaber
In Madrid and Melilla, NATO Parliamentarians Spotlight Shared Security Challenges on Europe’s Southern Flank
01 October 2025 Security on the Southern Flank is inseparable from that of the entire Alliance: challenges such as migration, terrorism and instability in NATO’s neighbourhood impact all Allies and demand collective responses. In a visit to Madrid...
Owner: NATO Parliamentary Assembly
Ukraine Drone Attacks Claim Two Lives in Russia's Belgorod
(MENAFN) Two civilians were killed and another seriously wounded after Ukrainian drones launched a series of attacks across Russia’s Belgorod region, according to regional governor Vyacheslav Gladkov. In a statement posted to Telegram, Gladkov...
Owner: Sawsan Dababneh & Ramzi AbdelJaber
Russian Strike on Zaporizhzhia Kills Two, Injures 14 in Ukraine
(MENAFN) Ukraine reported on Tuesday that a series of Russian strikes carried out overnight resulted in the deaths of two individuals and left 14 others wounded in the southeastern Zaporizhzhia region, including its Polohivskyi district. “Two...
Owner: Sawsan Dababneh & Ramzi AbdelJaber
Inventiva Appoints Andrew Obenshain as Chief Executive Officer
Daix (France), New York City (New York, United States), October 1, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the...
Moleculin Accelerates Recruitment in Phase 3 Acute Myeloid Leukemia “MIRACLE” Clinical Trial
European expansion in September across Georgia, Italy, Lithuania, Poland, Romania, Spain, and US 13 subjects recruited (treated, enrolled, or screened) Forecasts total recruitment of 20 or more subjects by end of September On track to recruit to...
Psychotherapist’s Writings on Love Offer Timely Wisdom Amid Global Division
The late Dr. Pieter Noomen, a psychotherapist and minister, left behind writings on love that feel startlingly relevant right now. LOS ANGELES, CA, UNITED STATES, October 1, 2025 /EINPresswire.com/ -- With wars raging from Ukraine to Myanmar and...
Cocrystal Pharma Receives FDA IND Clearance for Challenge Study of Oral Broad-Spectrum Protease Inhibitor CDI-988, a Potential First Antiviral for Norovirus Prevention and Treatment
There are currently no approved vaccines or treatments for norovirus infection Cocrystal’s CDI-988 is the first antiviral for the potential prevention and treatment of viral gastroenteritis caused by norovirus infections Phase 1b study is expected...